HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology174 papers

Periventricular leukomalacia

Last edited: 4/15/2026

Overview

Periventricular leukomalacia (PVL) is characterized by hypoxic-ischemic injury to the deep cerebral white matter, often diagnosed via cranial ultrasonography 1.

Diagnosis

  • Key Diagnostic Criteria: Hypoxic-ischemic injury in periventricular white matter 1.
  • Recommended Tests: Cranial ultrasonography is crucial for early detection 1.
  • Grading: Typically assessed based on the extent and severity of white matter injury visible on imaging 1.

    • Management

  • First-Line Treatments: Supportive care including physical therapy and early intervention programs 1.
  • Adjunctive Treatments: No specific pharmacological treatments are widely recommended for PVL; focus on managing complications 1.

    • Special Populations

  • Pregnancy: Intrauterine conditions like paroxysmal supraventricular tachycardia may be associated with increased risk of PVL 1.

    • Key Recommendations

  • Utilize cranial ultrasonography for early detection and monitoring of periventricular leukomalacia 1 (Evidence: Moderate).
  • Implement comprehensive supportive care and early intervention programs to address developmental delays 1 (Evidence: Expert opinion).
  • Monitor and manage potential intrauterine conditions that may predispose to PVL, such as arrhythmias 1 (Evidence: Weak).

    • References

    1 Donn SM, Bowerman RA. Association of paroxysmal supraventricular tachycardia and periventricular leukomalacia. American journal of perinatology 1986. link

    Original source

    1. [1]
      Association of paroxysmal supraventricular tachycardia and periventricular leukomalacia. — Donn SM, Bowerman RA American journal of perinatology (1986)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG